The Etiology of New-onset Status Epilepticus

This study will help to identify the causes of new epilepsy and provide a basis for the development of a rational and standardized diagnosis and treatment plan to reduce the rate of disability and death.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Status Epilepticus Nervous System Diseases Neurologic Manifestations Pathological Conditions, Signs and Symptoms Seizures Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Jie Liu

Chengdu, Sichuan, China

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Clinical diagnosis of Status Epilepticus
Sign the informed consent form

Exclusion criteria

Patients with previous epilepsy
Missing information such as basic information and treatment history
Long-term smoking, alcohol and drug abuse
Pregnant and breastfeeding women

Treatment and study plan

Perform autoimmune encephalitis titer tests

Diagnostic Test

We only follow up without intervention.

Other names: We only follow up without intervention.

Primary outcomes

Death

Time frame: 2021-12--2022-12

Sponsors and collaborators

Lead sponsor

Jie Liu

Other

Registry information

Official study title

Sichuan Academy of Medical Sciences - Sichuan Provincial People's Hospital

Important dates

Study start: 2021
Primary completion: 2022
Study completion: 2022
First posted: Dec 12, 2022
Registry last updated: Dec 15, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed